PhD-Studiengang Epidemiologie

Personen sitzen an Computern in einem Seminarraum

Der PhD-Studiengang „Epidemiologie“ ist ein dreijähriger Promotionsstudiengang im Bereich der epidemiologischen Forschung und wird von der Abteilung für Epidemiologie des HZI betrieben.

Der PhD-Studiengang ist ein Kooperationsprojekt der Abteilung für Epidemiologie, der  HZI Grad School und der HBRS (MHH). Nach erfolgreichem Abschluss erwerben die Studierenden in der Regel den Titel PhD oder in Einzelfällen Dr. rer nat.

Die Bewerbung und Zulassung zum PhD-Studiengang ist derzeit nur möglich, wenn eine externe Finanzierung gewährleistet ist (zum Beispiel über ein Stipendium oder Drittmittel).

Während des Studiums werden die PhD-Studierenden darauf vorbereitet, eigenständig epidemiologische Projekte durchzuführen. Studiengangsabsolventen streben Karrieren in Forschung und Wissenschaft, nationalen Institutionen des Gesundheitswesens, Ministerien, Krankenkassen, internationalen Organisationen oder in anderen nicht staatlichen Organisationen an.

Der PhD-Studiengang ermöglicht eine individuelle Karriereplanung und eine Ausbildung, die sich an persönlichen wissenschaftlichen Interessen ausrichtet.

Ziele des PhD-Studiengangs

  • Erfahrungen in der eigenständigen Planung, Leitung, Durchführung und Auswertung epidemiologischer Forschungsprojekte zu sammeln 
  • Vertiefende Kenntnisse zu epidemiologischen und statistischen Methoden zu erwerben
  • Beiträge zur wissenschaftlichen Evidenz in der Epidemiologie und Gesundheitsforschung zu leisten
  • Fähigkeiten zur Präsentation epidemiologischer Inhalte auf Konferenzen sowie in wissenschaftlichen Publikationen zu verbessern
  • Erfahrungen beim Lehren epidemiologischer Methoden zu erwerben
  • das Verständnis von Guter Epidemiologischer Praxis (GEP) zu fördern
Studiengang
Curriculum PhD Epidemiologie
Exemplarische Struktur des PhD-Studiengangs "Epidemiologie"
  • Der PhD-Studiengang erstreckt sich in der Regel über drei Jahre. 
  • Der Studiengang besteht aus individueller epidemiologischer Forschungstätigkeit (125 Credit Points) sowie aus einem obligatorischen begleitenden Lehrprogramm (55 Credit Points, mindestens 300 Lehreinheiten).
  • Das begleitende Lehrprogramm beinhaltet Vorlesungen und Seminare sowie epidemiologische Feldforschung in unserem Studienzentrum und im epidemiologischen Labor.
  • Unterrichtssprache der Lehrveranstaltungen ist Englisch. Der PhD-Studiengang wird durch ein Netzwerk von Doktorandinnen und Doktoranden, Post-Docs und Betreuern und Betreuerinnen unterstützt.
Bewerbung

Sehr Wichtig: Einwilligungserklärung Bewerbungsverfahren

Bewerben Sie sich postalisch oder per Email bei uns, bitten wir Sie, folgende Einwilligungserklärung Ihrer Bewerbung beizufügen:

„Hiermit willige ich, ………………………., ein, dass innerhalb des Bewerbungsverfahrens alle von mir mitgeteilten personenbezogene Daten durch das HZI verarbeitet werden können. Ich habe die Datenschutzerklärung des HZI zur Kenntnis genommen und bin über meine Rechte informiert.“

Ohne diese Einwilligungserklärung können wir Ihre Bewerbung nicht berücksichtigen/weiter bearbeiten und werden bereits eingegangene Bewerbungsunterlagen unverzüglich löschen.

Voraussetzungen für die Bewerbung:

  • Bei erster Kontaktaufnahme die Einwilligungserklärung zum Bewerbungsverfahren anfügen (siehe Hinweis oben)
  • Universitätsabschluss (Master oder gleichwertig) im Bereich Medizin, Zahnmedizin, Veterinärmedizin, Pharmazie, Naturwissenschaften oder in einem anderen Fachgebiet mit biomedizinischem oder gesundheitsrelevantem Schwerpunkt. Der Abschluss muss den Bewerber berechtigen, ein Promotionsstudium in Deutschland zu absolvieren (die Überprüfung erfolgt durch eine Behörde).
  • Fließende Englischkenntnisse in Wort und Schrift
  • Kenntnisse und Erfahrungen im Bereich epidemiologischer Methoden und Statistiken, die einem Abschluss wie MSE, MSc Epidemiologie, MPH oder MSAE entsprechen.  In Einzelfällen, in denen ein entsprechender formaler Abschluss fehlt, können auch erfolgreich absolvierte Kurse im Bereich Statistik und Epidemiologie mit 120 Kontaktstunden und/oder 10 ETCS anerkannt werden.
  • Einreichung vollständiger Bewerbungsunterlagen (per E-Mail), einschließlich eines Lebenslaufs (mit Auflistung der akademischen Abschlüsse), eines Motivationsschreibens, der Bachelor- und Master-Zertifikate zuzüglich Nachweis entsprechender Studienleistungen (in Originalsprache und englischer Übersetzung).
  • Einreichung eines Forschungsvorschlags (Vorlage „Application Exposé“), der sich vorzugsweise an eines der aufgeführten Forschungsgebiete richtet (Link).
  • Finanzierung: Finanzrahmen, der die Durchführung des Promotionsvorhabens ermöglicht (z.B. durch Drittmittel).
  • Erfolgreiche Präsentation des Projekts vor der PhD-Programmkommission.

Zulassung:

  • Die endgültige Entscheidung über die Aufnahme in das PhD-Programm "Epidemiologie" wird von der PhD-Programmkommission unter den oben genannten Voraussetzungen getroffen.
  • Nach der Zulassung erfolgt die Einschreibung an der MHH zum frühestmöglichen Zeitpunkt (Beginn des Winter- oder Sommersemesters).
  • Es gibt keine Lehrgebühren. Den regulären Semesterbeitrag der MHH, der das Semesterticket für den öffentlichen Verkehr beinhaltet, finden Sie auf der MHH-Website.
Publikationen

Liste der von unseren Studenten im Kontext des PhD-Studiengangs „Epidemiologie“ veröffentlichten Publikationen:

2023

Al-Mekhlafi A, and Klawonn F (2023) HiPerMAb: a tool for judging the potential of small sample size biomarker pilot studies, Int. J. Biostat.
https://doi.org/10.1515/ijb-2022-0063

Fernández Villalobos NV, Kessel B, Torres Páez JC, Strömpl J, Kerrinnes T, de la Hoz Restrepo FP, Strengert M and Krause G. (2023) Seroprevalence of Hepatitis E virus in children and adolescents living in urban Bogotá: An explorative cross-sectional study, Front Public Health 11, 981172. 
https://www.frontiersin.org/articles/10.3389/fpubh.2023.981172/full

Kessel B, Heinsohn T, Ott JJ, Wolff J, Hassenstein MJ and Lange B (2023) Impact of Covid-19 Pandemic and Anti-Pandemic Measures on Tuberculosis, Viral Hepatitis, Hiv/Aids and Malaria-a Systematic Review." PLOS Glob Public Health 3, no. 5.
https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0001018

Lotto Batista M, Rees EM, Gomez A, Lopez S, Castell S, Kucharski AJ, Ghozzi S, Muller GV and Lowe R. (2023) Towards a leptospirosis early warning system in northeastern Argentina, J R Soc Interface 20, 20230069.
https://royalsocietypublishing.org/doi/10.1098/rsif.2023.0069

 

2022

Fernández Villalobos NV, Kessel B, Rodiah I, Ott JJ, Lange B, Krause G (2022) Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis, PloS one 17: e0269253.
https://doi.org/10.1371/journal.pone.0269253

Coors A and Hassenstein MJ, Krause G, Kerrinnes T, Harries M, Breteler MMB and Castell S (2022) Regional seropositivity for Borrelia burgdorferi and associated risk factors: findings from the Rhineland Study, Germany, Parasit Vectors 15: 241.
https://www.ncbi.nlm.nih.gov/pubmed/35786209

Dulovic A, Kessel B, Harries M, Becker M, Ortmann J, Griesbaum J, Jüngling J, Junker D, Hernández P, Gornyk D et al. (2022) Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany. Front Immunol 13: 828053.
https://www.ncbi.nlm.nih.gov/pubmed/35251012

Jacobsen H,Strengert M, Maaß H, Ynga Durand MA, Kessel B, Harries M (…) Castell S, Gornyk D, Glöckner S,  Melhorn V, Kemmling Y, Lange B, et al. (2022) Diminished Neutralization Responses Towards Sars-Cov-2 Omicron Voc after Mrna or Vector-Based Covid-19 Vaccinations. medRxiv
https://www.medrxiv.org/content/10.1101/2021.12.21.21267898v2

Harries M, Jaeger VK, Rodiah I, Hassenstein MJ, Ortmann J, Dreier M, von Holt I, Brinkmann M, Dulovic A, Gornyk D, Hovardovska O, Kuczewski C, Kurosinki M, Schlotz, M, Schneiderhan-Marra N, Strengert M, Krause G, Sester M, Klein F, Petersmann A, Karch A and Lange B. (2022) Briding the gap – estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel, medRxiv, 2022.2012.2030.22284061.
https://sciety.org/articles/activity/10.1101/2022.12.30.22284061

Hassenstein MJ, Vanella, P (2022) Data Quality - Concepts and Problems, Encyclopedia 2, no. 1: 498-510.
DOI 10.3390/encyclopedia2010032

Hassenstein MJ, Janzen I., Krause G, Harries M, Melhorn V, Kerrinnes T, Kemmling Y and Castell S (2022) Seroepidemiology of Borrelia burgdorferi s.l. among German National Cohort (NAKO) Participants, Hanover, Microorganisms 10
https://www.mdpi.com/2076-2607/10/11/2286

Häring J, Hassenstein MJ, Becker M, Ortmann J, Junker D, Karch A, Berger K, Tchitchagua T, Leschnik O, Harries M, Gornyk D, Hernández P, Lange B, Castell S, Krause G, Dulovic A, Strengert M, and Schneiderhan-Marra N (2022) Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies, BMC Infectious Diseases 22, 859.
https://doi.org/10.1186/s12879-022-07863-9

Kwabla MP, Klett-Tammen CJ, Castell S (2022) Barriers and motivation for presumptive tuberculosis case referral: qualitative analysis among operators of community medicine outlets in Ghana, BMC Health Serv Res 22: 980.
https://www.ncbi.nlm.nih.gov/pubmed/35915498

Akmatov MK, Holstiege J, Dammertz L, Heuer J, Kohring C, Lotto-Batista M, et al. Epidemiology of Lyme borreliosis based on outpatient claims data of all people with statutory health insurance, Germany, 2019. Euro Surveill. 2022;27(32)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373599/

Rübsamen N, Garcia Voges B, Castell S, Klett-Tammen JC et al. (2022) Providing Laypeople with Results from Dynamic Infectious Disease Modelling Studies Affects Their Allocation Preference for Scarce Medical Resources—a Factorial Experiment. BMC Public Health 22, no. 1 (2022/03/23 2022): 572.
https://dx.doi.org/10.1186/s12889-022-13000-7

Silenou BC, Verset C, Kaburi BB, Leuci O, Ghozzi S, Duboudin C, Krause G (2022) A Novel Tool for Real-time Estimation of Epidemiological Parameters of Communicable Diseases Using Contact-Tracing Data: Development and Deployment. JMIR Public Health Surveill 8: e34438.
https://publichealth.jmir.org/2022/5/e34438

Umutesi J, Nsanzimana S, Yingkai Liu C, Vanella P, Ott JJ, Krause G (2022) Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting, BMC Infect Dis 22: 500.
https://publichealth.jmir.org/2022/5/e34438

 

2021

Al-Mekhlafi A, Sühs K-W, Schuchardt S, Kuhn M, Müller-Vahl K, Trebst C, Skripuletz T, Klawonn F, Stangel M, Pessler F (2021) Elevated Free Phosphatidylcholine Levels in Cerebrospinal Fluid Distinguish Bacterial from Viral CNS Infections. Cells 10: 1115.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148106/

Lambert JF, Stete K, Balmford J, Bockey A, Kern W, Rieg S, Boeker M, Lange B (2021) Reducing burden from respiratory infections in refugees and immigrants: a systematic review of interventions in OECD, EU, EEA and EU-applicant countries, BMC Infect Dis 21: 872.
https://pubmed.ncbi.nlm.nih.gov/34445957/

Fernández Villalobos NV, Ott JJ, Klett-Tammen CJ, Bockey A, Vanella P, Krause G, Lange B (2021) Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis, Systematic Reviews 10: 194.
https://doi.org/10.1186/s13643-021-01732-3

Gornyk D, Scharlach M, Buhr-Riehm B, Klett-Tammen CJ, Eberhard S, Stahmeyer JT, Großhennig A, Smith A, Meinicke S, Bautsch W et al. (2021) Effectiveness of trainings of General Practitioners on antibiotic stewardship: A pragmatic quasi-experimental study in a controlled before-after design in South-East-Lower Saxony, Germany (WASA). Front Pharmacol 12: 533248.
https://www.ncbi.nlm.nih.gov/pubmed/33967743

Gornyk D, Harries M, Glöckner S, Strengert M, Kerrinnes T, Heise JK, et al. SARS-CoV-2 Seroprevalence in Germany. Dtsch Arztebl Int. 2021;118(48):824-31.
https://www.aerzteblatt.de/int/archive/article/221933

Kwabla MP, Amuasi JH, Krause G, Klett-Tammen C J, Castell S (2021) Referral of presumptive TB among operators of community medicine outlets, Int J Tuberc Lung Dis 25: 982-989.
https://pubmed.ncbi.nlm.nih.gov/34886927/

Lotto Batista M, Behrens C, Castell S (2021) Der Einfluss des Klimawandels auf die Ausbreitung von Infektionserkrankungen – am Beispiel der Lyme-Borreliose. Buch: Versorgungs-Report: Klima und Gesundheit, 11, 145-155.
https://www.mwv-open.de/site/chapters/e/10.32745/9783954666270-11/

Nguyen MTH, Krause G, Keller-Stanislawski B, Glöckner S, Mentzer D, Ott JJ (2021) Postmarketing Safety Monitoring After Influenza Vaccination Using a Mobile Health App: Prospective Longitudinal Feasibility Study. JMIR Mhealth Uhealth 9: e26289.
https://doi.org/10.2196/26289

Silenou BC, Nyirenda, J. L. Z., Zaghloul, A., Lange, B., Doerrbecker, J., Schenkel, K, Krause G (2021) Availability and Suitability of Digital Health Tools in Africa for Pandemic Control: Scoping Review and Cluster Analysis, JMIR public health and surveillance 7: e30106-e30106.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738990/

Perrocheau A, Brindle H, Roberts C, Murthy S, Shetty S, Martin AIC, Marks M, Schenkel K, Silenou B, et al. (2021) Data collection for outbreak investigations: process for defining a minimal data set using a Delphi approach. BMC Public Health 21: 2269.
https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-12206-5

Umutesi J, Klett-Tammen C, Nsanzimana S, Krause G, Ott JJ (2021) Cross-sectional study of chronic hepatitis B virus infection in Rwandan high-risk groups: unexpected findings on prevalence and its determinants, BMJ open 11: e054039.
http://bmjopen.bmj.com/content/11/12/e054039.abstract

 

2020

Al-Mekhlafi A, Becker T, Klawonn F (2020) Sample size and performance estimation for biomarker combinations based on pilot studies with small sample sizes. Communications in Statistics - Theory and Methods: 1-15.
https://doi.org/10.1080/03610926.2020.1843053

Apenteng OO, Osei PP, Oduro B, Kwabla MP, Ismail NA (2020) The impact of implementing HIV prevention policies therapy and control strategy among HIV and AIDS incidence cases in Malaysia. Infectious Disease Modelling 5: 755-765.
https://doi.org/10.1016/j.idm.2020.09.009

Bockey AJ, Janda A, Braun C, Müller A-M, Stete K, Kern WV, Rieg SR, Lange B (2020) Patient satisfaction & use of health care: a cross-sectional study of asylum seekers in the Freiburg initial reception centre. BMC Health Services Research 20: 709.
https://doi.org/10.1186/s12913-020-05579-7

Hassenstein MJ, Aarabi G, Ahnert P, Becher H, Franzke C-W, Fricke J, Krause G, Glöckner S, Gottschick C, Karch A, et al. (2020) Selbst berichtete Infektionen in der NAKO Gesundheitsstudie – Einordnung in die gegenwärtige Forschungslandschaft. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 63: 404-414.
https://doi.org/10.1007/s00103-020-03114-x

Luo Y, Möhn N, Al-Mekhlafi A, Schuchardt S, Skripuletz T, Sühs W, Pessler F, Stangel M. (2020). Targeted metabolomic profiling of cerebrospinal fluid from patients with progressive multifocal leukoencephalopathy. PLoS One, 15(11), e0242321.
https://doi.org/10.1371/journal.pone.0242321

Nguyen MTH, Ott JJ, Caputo M, Keller-Stanislawski B, Klett-Tammen CJ, Linnig S, Mentzer D, Krause G (2020) User preferences for a mobile application to report adverse events following vaccination. Pharmazie 75: 27-31.
https://www.ncbi.nlm.nih.gov/pubmed/32033630

Silenou, B, Tom-Aba D, Adeoye O, Arinze C, Oyiri F, Suleman A, Yinka-Ogunleye A, Dörrbecker J, Ihekweazu C, Krause G (2020) Use of Surveillance Outbreak Response Management and Analysis System for Human Monkeypox Outbreak, Nigeria, 2017-2019. Emerging infectious diseases 26: 345-349.
https://www.ncbi.nlm.nih.gov/pubmed/31961314

Tom-Aba D, Silenou BC, Doerrbecker J, Fourie C, Leitner C, Wahnschaffe M, Strysewske M, Arinze CC, Krause G (2020) The Surveillance Outbreak Response Management and Analysis System (SORMAS): Digital Health Global Goods Maturity Assessment. JMIR public health and surveillance 6: e15860-e15860.
https://pubmed.ncbi.nlm.nih.gov/32347809

 

2019

Caputo M, Horn J, Karch A, Akmatov MK, Becher H, Braun B, . . . Mikolajczyk R. (2019). Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort. BMC Infect Dis, 19(1), 99.
https://www.ncbi.nlm.nih.gov/pubmed/30700258

Caputo M, Stumpe V, Rubsamen N, Mikolajczyk RT, Karch A. (2019). Implementation of preventive measures against tick-borne infections in a non-endemic area for tick-borne encephalitis – Results from a population-based survey in Lower Saxony, Germany. Ticks Tick Borne Dis, 10(3), 614-620.
https://www.ncbi.nlm.nih.gov/pubmed/30797728

Caputo M, Zoch-Lesniak B, Karch A, Vital M, Meyer F, Klawonn F, . . . Mikolajczyk RT. (2019). Bacterial community structure and effects of picornavirus infection on the anterior nares microbiome in early childhood. BMC Microbiol, 19(1), 1.
https://www.ncbi.nlm.nih.gov/pubmed/30616583

Grylka-Baeschlin S, Clarke M, Begley C, Daly D, Healy P, Nicoletti J, . . . Gross MM. (2019). Labour characteristics of women achieving successful vaginal birth after caesarean section in three European countries. Midwifery, 74, 36-43.
https://www.ncbi.nlm.nih.gov/pubmed/30925415

Raupach-Rosin H, Rübsamen N, Schütte G, Raschpichler G, Chaw PS, Mikolajczyk R. (2019). Knowledge on Antibiotic Use, Self-Reported Adherence to Antibiotic Intake, and Knowledge on Multi-Drug Resistant Pathogens – Results of a Population-Based Survey in Lower Saxony, Germany. 10(776).
https://www.frontiersin.org/article/10.3389/fmicb.2019.00776

Silenou BC, Avalos M, Helmer C, Berr C, Pariente A, Jacqmin-Gadda H. (2019). Health administrative data enrichment using cohort information: Comparative evaluation of methods by simulation and application to real data. PLoS One, 14(1), e0211118.
https://pubmed.ncbi.nlm.nih.gov/30703112/

Zoch-Lesniak B, Ware RS, Grimwood K, Lambert SB. (2019). The Respiratory Specimen Collection Trial (ReSpeCT): A Randomized Controlled Trial to Compare Quality and Timeliness of Respiratory Sample Collection in the Home by Parents and Healthcare Workers From Children Aged <2 Years. J Pediatric Infect Dis Soc.
https://www.ncbi.nlm.nih.gov/pubmed/30657971

 

2018

Akmatov MK, Rubsamen N, Deyneko IV, Karch A, Mikolajczyk RT. (2018). Poor knowledge of vaccination recommendations and negative attitudes towards vaccinations are independently associated with poor vaccination uptake among adults - Findings of a population-based panel study in Lower Saxony, Germany. Vaccine, 36(18), 2417-2426.
https://www.sciencedirect.com/science/article/pii/S0264410X18304067?via%3Dihub

Chaw PS, Schlinkmann KM, Raupach-Rosin H, Karch A, Pletz MW, Huebner J, Nyan O, Mikolajczyk R. (2018). Antibiotic use on paediatric inpatients in a teaching hospital in the Gambia, a retrospective study. Antimicrob Resist Infect Control, 7, 82.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048718/

Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, . . . Mikolajczyk RT. (2018). Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study. BMC Medicine, 16(1), 3.
https://doi.org.1186/s12916-017-0983-5

Horn J, Hoodgarzadeh M, Klett-Tammen CJ, Mikolajczyk RT, Krause G, Ott JJ. (2018). Epidemiologic estimates of hepatitis E virus infection in European countries. J Infect, 77(6), 544-552.
https://www.ncbi.nlm.nih.gov/pubmed/30268515

Limaye D, Limaye V, Fortwengel G, Krause G. (2018). Self-medication practices in urban and rural areas of western India: a cross sectional study. International Journal of Community Medicine And Public Health, 5(7), 2672.
https://www.ijcmph.com/index.php/ijcmph/article/view/3266

Obenauer J, Rübsamen N, Castell S, Hoodgarzadeh M, Klett-Tammen CJ, Mikolajczyk RT, Karch A. (2018). Perceptions of Zika virus risk in Germany in 2016. Eur J Public Health, 28(1), 139-144.
https://www.ncbi.nlm.nih.gov/pubmed/29106547

Obenauer J, Rübsamen N, Garsevanidze E, Karch A, Mikolajczyk RT. (2018). Changes in risk perceptions during the 2014 Ebola virus disease epidemic: results of two consecutive surveys among the general population in Lower Saxony, Germany. BMC Public Health, 18(1), 628.
https://doi.org/10.1186/s12889-018-5543-1

Schlinkmann KM, Bakuli A, Karch A, Meyer F, Dreesman J, Monazahian M, Mikolajczyk R. (2018). Transmission of respiratory and gastrointestinal infections in German households with children attending child care. Epidemiology and Infection, 146(5), 627-632.
https://pubmed.ncbi.nlm.nih.gov/29478420/

Tom-Aba D, Nguku PM, Arinze CC, Krause G. (2018). Assessing the Concepts and Designs of 58 Mobile Apps for the Management of the 2014-2015 West Africa Ebola Outbreak: Systematic Review. JMIR Public Health Surveill, 4(4), e68.
https://pubmed.ncbi.nlm.nih.gov/30373727/

Tom-Aba D, Toikkanen SE, Glockner S, Adeoye O, Mall S, Fahnrich C, . . . Krause G. (2018). User Evaluation Indicates High Quality of the Surveillance Outbreak Response Management and Analysis System (SORMAS) After Field Deployment in Nigeria in 2015 and 2018. Stud Health Technol Inform, 253, 233-237.
https://pubmed.ncbi.n https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048718/ lm.nih.gov/30147081/

 

2017

Bakuli A, Klawonn F, Karch A, Mikolajczyk R. (2017). Effects of pathogen dependency in a multi-pathogen infectious disease system including population level heterogeneity - a simulation study. Theor Biol Med Model, 14(1), 26.
https://www.ncbi.nlm.nih.gov/pubmed/29237462

Chaw PS, Schlinkmann KM, Raupach-Rosin H, Karch A, Pletz MW, Huebner J, Mikolajczyk R. (2017). Knowledge, attitude and practice of Gambian health practitioners towards antibiotic prescribing and microbiological testing: a cross-sectional survey. Transactions of The Royal Society of Tropical Medicine and Hygiene, 111(3), 117-124.
https://doi.org/10.1093/trstmh/trx027

Cuny C, Arnold P, Hermes J, Eckmanns T, Mehraj J, Schoenfelder S, . . . Witte W. (2017). Occurrence of cfr-mediated multiresistance in staphylococci from veal calves and pigs, from humans at the corresponding farms, and from veterinarians and their family members. Vet Microbiol, 200, 88-94.
https://www.ncbi.nlm.nih.gov/pubmed/27102205

Damm O, Horn J, Mikolajczyk RT, Kretzschmar MEE, Kaufmann AM, Deleré Y, . . . Greiner W. (2017). Cost-effectiveness of human papillomavirus vaccination in Germany. Cost Effectiveness and Resource Allocation, 15(1), 18.
https://doi.org/10.1186/s12962-017-0080-9

Karo B, Krause G, Castell S, Kollan C, Hamouda O, Haas W, ClinSurv HIVSG. (2017). Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy. BMC Infect Dis, 17(1), 517.
https://www.ncbi.nlm.nih.gov/pubmed/28743248

Limaye D, Limaye V, Krause G, Fortwengel G. (2017). A systematic review of the literature on survey questionnaires to assess self-medication practices. International Journal of Community Medicine and Public Health, 2017(4(8)), 2620-2631.
https://www.ijcmph.com/index.php/ijcmph/article/view/1731

Limaye D, Limaye V, Krause G, Fortwengel G. (2017). A Systematic Review of the Literature to Assess Self-medication Practices. Ann Med Health Sci Res, 7, 1-15.
https://serwiss.bib.hs-hannover.de/frontdoor/index/index/docId/1131

Meyer F, Karch A, Schlinkmann KM, Dreesman J, Horn J, Rubsamen N, Sudradjat H, Schubert R, Mikolajczyk R. (2017). Sociodemographic determinants of spatial disparities in early childhood caries: An ecological analysis in Braunschweig, Germany. Community Dent Oral Epidemiol, 45(5), 442-448.
https://www.ncbi.nlm.nih.gov/pubmed/28547864

Nguyen VK, Hernandez-Vargas EA. (2017). Windows of opportunity for Ebola virus infection treatment and vaccination. Sci Rep, 7(1), 8975.
https://www.ncbi.nlm.nih.gov/pubmed/28827623

Rubsamen N, Akmatov MK, Castell S, Karch A, Mikolajczyk RT. (2017). Comparison of response patterns in different survey designs: a longitudinal panel with mixed-mode and online-only design. Emerg Themes Epidemiol, 14(1), 4.
https://www.ncbi.nlm.nih.gov/pubmed/28344629

Rubsamen N, Akmatov MK, Castell S, Karch A, Mikolajczyk RT. (2017). Factors associated with attrition in a longitudinal online study: results from the HaBIDS panel. BMC Med Res Methodol, 17(1), 132.
https://www.ncbi.nlm.nih.gov/pubmed/28859617

Schlinkmann KM, Bakuli A, Mikolajczyk R. (2017). Incidence and comparison of retrospective and prospective data on respiratory and gastrointestinal infections in German households. BMC Infectious Diseases, 17(1), 336.
https://doi.org/10.1186/s12879-017-2434-5

Schlinkmann KM, Glöckner S, Adeoye O, Ameh C, Ihekweazu C, Nguku P, . . . Krause G. (2017). Poster: Surveillance and Outbreak Response Management and Analysis System (SORMAS) - an open source mHealth tool. Paper presented at the 3rd African Conference on Emerging Infectious Disease and Biosecurity, Accra, Ghana.

Schweitzer A, Akmatov MK, Krause G. (2017). Hepatitis B vaccination timing: results from demographic health surveys in 47 countries. Bulletin of the World Health Organization, 95(3), 199-209G.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328113/

Zoch B, Gunther A, Karch A, Mikolajczyk R. (2017). Effect of Disease Definition on Perceived Burden of Acute Respiratory Infections in Children: A Prospective Cohort Study Based on Symptom Diaries. Pediatr Infect Dis J, 36(10), 956-961.
https://www.ncbi.nlm.nih.gov/pubmed/28399058

 

2016

Grylka-Baeschlin S, Petersen A, Karch A, Gross MM. (2016). Labour duration and timing of interventions in women planning vaginal birth after caesarean section. Midwifery, 34, 221-229.
https://doi.org/10.1016/j.midw.2015.11.004

Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B,Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT. (2016). Current and future effects of varicella and herpes zoster vaccination in Germany – Insights from a mathematical model in a country with universal varicella vaccination. Hum Vaccin Immunother, 12(7), 1766-1776.
https://doi.org/10.1080/21645515.2015.1135279

Karo B, Krause G, Hollo V, van der Werf MJ, Castell S, Hamouda O, Haas W. (2016). Impact of HIV infection on treatment outcome of tuberculosis in Europe. AIDS, 30(7), 1089-1098.
https://www.ncbi.nlm.nih.gov/pubmed/26752278

Mehraj J, Witte W, Akmatov MK, Layer F, Werner G, Krause G. (2016). Epidemiology of Staphylococcus aureus Nasal Carriage Patterns in the Community. In M Stadler, P Dersch (Eds.), How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives (pp. 55-87). Cham: Springer International Publishing.
https://doi.org/10.1007/82_2016_497

Nguyen VK, Klawonn F, Mikolajczyk R, Hernandez-Vargas EA. (2016). Analysis of Practical Identifiability of a Viral Infection Model. PLoS One, 11(12), e0167568.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0167568

Obenauer J, Rübsamen N, Castell S, Hoodgarzadeh M, Klett-Tammen CJ, Mikolajczyk R. (2016). Perceptions of Zika virus risk in Lower Saxony in 2016. Paper presented at the DZIF Annual Meeting. German Center for Infections Reearch (DZIF), Flora, Cologne.
 https://academic.oup.com/eurpub/article/28/1/139/3924511

Raupach-Rosin H, Rubsamen N, Szkopek S, Schmalz O, Karch A, Mikolajczyk R, Castell S. (2016). Care for MRSA carriers in the outpatient sector: a survey among MRSA carriers and physicians in two regions in Germany. BMC Infect Dis, 16(1), 184.
https://www.ncbi.nlm.nih.gov/pubmed/27112442

Schlinkmann KM, Raupach-Rosin H, Hübner J, Mikolajczyk R. (2016). Infection prevention at preschool age - What is reasonable? [Infektionsprävention im Kindergartenalter -Was ist sinnvoll?]. Tägliche Praxis, 58(1), 7-19.
 https://www.researchgate.net/publication/307540464_Infection_prevention_at_preschool_age_-_What_is_reasonable

 

2015

Damm O, Horn J, Mikolajczyk R, Greiner W, Siedler A, Weidemann F, . . . Ultsch B. (2015). PIN70 - Health Economic Evaluation of Different Vaccination Strategies Against Varicella and Herpes Zoster in Germany. Value in Health, 18(7), A588.
https://doi.org/10.1016/j.jval.2015.09.1503

Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O. (2015). Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health, 15(1), 533.
https://doi.org/10.1186/s12889-015-1861-8

Karo B, Hauer B, Hollo V, van der Werf MJ, Fiebig L, Haas W. (2015). Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011. Euro Surveill, 20(49).
https://pubmed.ncbi.nlm.nih.gov/26676247/

Nguyen VK, Binder SC, Boianelli A, Meyer-Hermann M, Hernandez-Vargas EA. (2015). Ebola virus infection modeling and identifiability problems. Front Microbiol, 6, 257.
https://www.ncbi.nlm.nih.gov/pubmed/25914675

Rubsamen N, Castell S, Horn J, Karch A, Ott JJ, Raupach-Rosin H, Zoch B, Krause G, Mikolajczyk RT. (2015). Ebola risk perception in Germany, 2014. Emerg Infect Dis, 21(6), 1012-1018.
https://www.ncbi.nlm.nih.gov/pubmed/25989020

Schweitzer A, Akmatov MK, Kindler F, Kemmling Y, Kreienbrock L, Krause G, Pessler F. (2015). The impact of distance and duration of travel on participation rates and participants' satisfaction: results from a pilot study at one study centre in Pretest 2 of the German National Cohort. BMJ Open, 5(8), e007461.
http://www.ncbi.nlm.nih.gov/pubmed/26297358

Schweitzer A, Krause G, Pessler F, Akmatov MK. (2015). Improved coverage and timing of childhood vaccinations in two post-Soviet countries, Armenia and Kyrgyzstan. BMC Public Health, 15(1), 798.
https://pubmed.ncbi.nlm.nih.gov/26285702

Tom-Aba D, Olaleye A, Olayinka AT, Nguku P, Waziri N, Adewuyi P, . . . Shuaib F. (2015). Innovative technological approach to ebola virus disease outbreak response in Nigeria using the open data kit and form hub technology. PLoS One, 10(6).
https://pubmed.ncbi.nlm.nih.gov/26115402/

Zoch B, Karch A, Dreesman J, Monazahian M, Baillot A, Mikolajczyk RT. (2015). Feasibility of a birth cohort study dedicated to assessing acute infections using symptom diaries and parental collection of biomaterials. BMC Infectious Diseases, 15(1), 436.
https://doi.org/10.1186/s12879-015-1189-0

 

2014

Akmatov MK, Mehraj J, Gatzemeier A, Strömpl J, Witte W, Krause G, Pessler F. (2014). Serial home-based self-collection of anterior nasal swabs to detect Staphylococcus aureus carriage in a randomized population-based study in Germany. Int J Infect Dis, 25, 4-10.
https://pubmed.ncbi.nlm.nih.gov/24813875/

Damm O, Horn J, Schmidt T, Neubauer S, Zeidler J, Mikolajczyk R, . . . Ultsch B. (2014). Epidemiology and Costs of Varicella and Herpes Zoster in Germany. Value Health, 17(7), A670-671.
https://www.ncbi.nlm.nih.gov/pubmed/27202458

Hense S, Hillebrand K, Horn J, Mikolajczyk R, Schulze-Rath R, Garbe E. (2014). HPV vaccine uptake after introduction of the vaccine in Germany: an analysis of administrative data. Hum Vaccin Immunother, 10(6), 1729-1733.
https://pubmed.ncbi.nlm.nih.gov/24637921

Mehraj J, Akmatov MK, Strompl J, Gatzemeier A, Layer F, Werner G, Pieper DH, Medina E, Witte W, Pessler F, Krause G. (2014). Methicillin-sensitive and methicillin-resistant Staphylococcus aureus nasal carriage in a random sample of non-hospitalized adult population in northern Germany. PLoS One, 9(9), e107937.
http://www.ncbi.nlm.nih.gov/pubmed/25251407

 

2013

Horn J, Damm O, Kretzschmar ME, Delere Y, Wichmann O, Kaufmann AM, Garbe E, Kramer A, Greiner W, Mikolajczyk RT. (2013). Estimating the long-term effects of HPV vaccination in Germany. Vaccine, 31(19), 2372-2380.
https://pubmed.ncbi.nlm.nih.gov/23518405/

Mikolajczyk RT, Kraut AA, Horn J, Schulze-Rath R, Garbe E. (2013). Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study. Sex Transm Dis, 40(1), 28-31.
https://pubmed.ncbi.nlm.nih.gov/23250300/

Lehre

Example modules:

  • Good Epidemiological Practice
  • Surveillance and Outbreak Investigations
  • Systematic Reviews and Meta-Analysis
  • Machine Learning
PhD-Student:innen
Annabelle Bockey
Annabelle Bockey
Doktorandin
Epidemiologie
HZI Campus
Anne Hallet
Anne Hallet
Doktorandin
Epidemiologie
HZI Campus
Robyn Kettlitz
Robyn Kettlitz
Doktorand
Epidemiologie
HZI Campus
Martin Lotto
Martin Lotto
Doktorand
Epidemiologie
HZI Campus
Dörthe Meyerdierks
Dörthe Meyerdierks
Doktorandin
Epidemiologie
HZI Campus
Maren Wieder
Maren Wieder
Doktorandin
Epidemiologie
HZI Campus

Kontakt

Sprecher:
Prof. Dr. Gérard Krause

Koordinatorinnen (gemeinsam): 
Dr. Berit Lange
Dr. Carolina Klett-Tammen

Abteilung für Epidemiologie
Helmholtz Zentrum für Infektionsforschung
Inhoffenstraße 7
38124 Braunschweig

Studiengangsbüro:
Jennifer Birnschein

Telefon: 0531 6181 - 3136
E-Mail